Study Group: Pulmonologists (EU)(?)
Council Members in this Study Group: 243
Request a survey with this Study Group
Leading Experts in this Study Group
Department Chair of Cardiology
Erasme Hospital
Robert Naeije, MD, PhD, is Professor and Chairman of the Department of Physiology and Pathophysiology at Erasme University Hospital and runs the pulmonary hypertension clinic. Dr. Naeije's main area of expertise is pulmonary circulation. His basic research is in the pathobiology of pulmonary hypertension....
Director of the Pulmonary Vascular Diseases Clinic
Erasme Hospital
Jean-Luc Vachiery, MD, FESC, is Professor of Cardiology and Head of the Pulmonary Vascular Diseases Unit at Erasme Hospital, a European expert PAH center in Belgium. Currently, Dr. Vachiery is involved as a Steering Committee Member and Principal Investigator or Co-Investigator in all major trials on...
Head of Sleep Medicine
Montpellier University Hospital Center
Yves Dauvilliers, MD, is Division Head of Sleep Medicine at the University Hospital of Montpellier, France. Dr. Dauvilliers has expertise in the treatment of all sleep disorders. His basic research interests, using electrophysiological and genetic techniques, are narcolepsy, parasomnia and sleep with...
Hossein Ghofrani, MDPhysician
Justus Liebig Universitat Giessen
Hossein Ardeschir (Ardi) Ghofrani, MD, is Lead physician of the Pulmonary Hypertension Centre at the University of Giessen Lung Center (UGLC), Germany. Prof. Ghofrani is a Reviewer for various high impact scientific journals including Lancet, AJRCCM, Circulation, and Circulation research amongst others....
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
This article implicates that, while new uses for old drugs are terrifically attractive for drug companies this somehow lessens the drive for them to find new original substances. Of course it is nice to get a new market without paying USD 500 000 000 which is the going rate for a new drug through all...
This is a good inhaler but there is no current evidence the drug is signifcantly better than spiriva.
New drugs need 2 year data!
This is exciting news about the improvement in patient outcomes. it is unfortunate that they decdied to end the trial early however as with just 41 patients in the trial - any adverse events that the treatment might cause may arise during wider usage.
Recent renewed interest in a failed anti-cytokine approach for asthma.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Academic Institution*
- Government/Military Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Office Based Private Practice or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Division Head
- Physician - Director
- Professor
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms